Guidelines

Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors

See all (791)

rita carsetti

Bambino Gesù Children's Hospital (IRCCS)

Rome, Italy

Specialty Chief Editor

Vaccines and Molecular Therapeutics
denise l. doolan

Australian Institute of Tropical Health and Medicine, James Cook University

Cairns, Australia

Specialty Chief Editor

Vaccines and Molecular Therapeutics
selidji todagbe agnandji

Centre de Recherche Médicales de Lambaréné

Lambaréné, Gabon

Associate Editor

Vaccines and Molecular Therapeutics
nahid ali

Indian Institute of Chemical Biology (CSIR)

Kolkata, India

Associate Editor

Vaccines and Molecular Therapeutics

Navigation group

Vaccines and Molecular Therapeutics

Guidelines

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Editors

rita carsetti

denise l. doolan

selidji todagbe agnandji

nahid ali

Articles

Phage-resistance alters Lipid A reactogenicity: a new strategy for LPS-based conjugate vaccines against Salmonella Rissen

Next-generation adjuvant systems containing furfurman drives potent adaptive immunity and host defense as a foot-and-mouth disease vaccine adjuvant

A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer

GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer

Research Topics

Advancing Haemoprotozoan Vaccinology: Interdisciplinary Approaches and Challenges

Data-Driven Vaccine Design for Microbial-Associated Diseases

Mucosal Immunity after Vaccination

Vaccines and Breakthrough Infections